Loading...
Projects / Programmes source: ARIS

Renal anemia

Research activity

Code Science Field Subfield
3.07.00  Medical sciences  Metabolic and hormonal disorders   

Code Science Field
B560  Biomedical sciences  Urology, nephrology 
Keywords
anemia, renal failure, dialysis
Evaluation (rules)
source: COBISS
Researchers (12)
no. Code Name and surname Research area Role Period No. of publicationsNo. of publications
1.  01972  PhD Andrej Bren  Cardiovascular system  Head  2003 - 2005 
2.  10649  PhD Jadranka Buturović-Ponikvar  Cardiovascular system  Researcher  2003 - 2005 
3.  01975  Andrej Guček  Cardiovascular system  Researcher  2003 - 2005 
4.  01977  PhD Aljoša Kandus  Cardiovascular system  Researcher  2003 - 2005 
5.  20954  Mida Kandus    Technical associate  2003 - 2005 
6.  01982  PhD Radoslav Kveder  Cardiovascular system  Researcher  2003 - 2005 
7.  06203  PhD Marko Malovrh  Cardiovascular system  Researcher  2003 - 2005 
8.  24468  Katarina Omahen  Microbiology and immunology  Junior researcher  2004 - 2005 
9.  23258  PhD Jernej Pajek  Cardiovascular system  Researcher  2003 - 2005 
10.  23499  Barbara Ponikvar    Technical associate  2004 - 2005 
11.  01987  PhD Rafael Ponikvar  Cardiovascular system  Researcher  2003 - 2005 
12.  08767  Janez Varl  Cardiovascular system  Researcher  2003 - 2005 
Organisations (1)
no. Code Research organisation City Registration number No. of publicationsNo. of publications
1.  0312  University Medical Centre Ljubljana  Ljubljana  5057272000  125 
Abstract
The objective of this study would be an analysis of renal anemia in chronic dialysis patients. We want to find out in which percentage is needed the treatment with iron and epoetin, to investigate whether patients on peritoneal dialysis need lower dosage of iron and epoetin at the beginning of the treatment in respect to later period and in respect to hemodialysis patients, if the newer application of epoetin with pen is more suitable than in syringes, and what are the possible influences on anemia and its treatment (secondary hyperparathyroidism, inflammation states, drugs: some vitamins, ACE inhibitors, aluminium phosphate binders etc). It would also be of interest whether one weekly dosage of epoetin would be as effective as devided in two or three weekly doses. The side effects of iron and epoetin treatment will aso be checked.
Views history
Favourite